Growth Metrics

Jaguar Health (JAGX) Capital Expenditures (2016 - 2025)

Jaguar Health (JAGX) has disclosed Capital Expenditures for 6 consecutive years, with -$13000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures changed N/A to -$13000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$13000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $41000.0 for FY2025, 156.25% up from the prior year.
  • Capital Expenditures for Q4 2025 was -$13000.0 at Jaguar Health, up from -$1.1 million in the prior quarter.
  • The five-year high for Capital Expenditures was $6000.0 in Q1 2021, with the low at -$1.1 million in Q3 2022.
  • Average Capital Expenditures over 3 years is -$371333.3, with a median of -$13000.0 recorded in 2025.
  • Peak annual rise in Capital Expenditures hit 14.29% in 2021, while the deepest fall reached 14.29% in 2021.
  • Over 3 years, Capital Expenditures stood at $6000.0 in 2021, then tumbled by 18550.0% to -$1.1 million in 2022, then soared by 98.83% to -$13000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at -$13000.0, -$1.1 million, and $6000.0 for Q4 2025, Q3 2022, and Q1 2021 respectively.